2Doughty RN, Whalley GA, Walsh HA, et al. Effects of carvedilol on left ventricular remodeling after acute mycardial infarction: the CAPRI CORN Echo Substudy. Circulation, 2004, 109 : 201-206. 被引量：1
4Takahashi M, Takeda S, Kurokawa S, et al.Cyclic GMP production by ANP,BNP,and NO during worsening and improvement of chronic heart. JPN Heart J,2003,44 : 713-724. 被引量：1
5Packer M, Coats AJ, Fowler MB, et al.Effect of carvedilol on survival in severe chronic heart failure.N Engl J Med,2001,344 : 1651-1658. 被引量：1
41，Gavg R,Yusuf S.Overview of randomized trial of angiotensin -converting enzyme inhibitors on mortality and morbidity in patients with heart failure.Collaborative Group on ACE inhibitors.JAMA,1995;273(18):1450 被引量：1
52，CIBIS-Ⅱ Investigators and Committees.The cardiac insufficiency bisoprolol study Ⅱ(CIBIS-Ⅱ)a randomised trial.Lancet,1999;353(9146):9 被引量：1
63，MERIT-HF Study Group.Effect of metoprolol CR/XL in chronic heart failure:Metoprolol CR/XL Randomised Intervention Trial in congestive Heart Failure(MERIT-HF).Lancet,1999;353(9169):2001 被引量：1
7Goto Y,Ogihara T.Effects of carvedilol on serum lipids in patient with essentialhypertension J Cardiovasc Pharmacol, 1991,18 ( suppL 4): S45. 被引量：1
8Erika Von M, Gisbert S, Klaus S, et al. New Cardiovascular Drugs.New York: RavenPress, 1987,135-153. 被引量：1
9Packer M, Bristow MR, Cohn JN, et al. The effect of carvedilol on morbidity andmortality in patients with chronic heart failure. N Eng J Med, 1996,334(21): 1349-1355. 被引量：1
10Colucci WS, Packer M, Bristow MR, et al. Carvedilol inhibits Clinical Progressionin Patients with mild systems of heart failure. Circulation,1996,94(11) :2800-2806. 被引量：1
